Redefining Type 2 diabetes: ‘Diabesity’ or ‘Obesity Dependent Diabetes Mellitus’?
- 1 October 2000
- journal article
- review article
- Published by Wiley in Obesity Reviews
- Vol. 1 (2) , 57-59
- https://doi.org/10.1046/j.1467-789x.2000.00013.x
Abstract
Type 2 diabetes is considered by diabetes physicians as a complex and heterogeneous disease with a poorly understood aetiology, apart from the fact that there is a strong genetic propensity that becomes overt when exposed to a typical Western lifestyle. Our clinical targets are now moving from controlling the disease to preventing it. Do we need to await more research on the aetiology and pathophysiology before establishing a preventive strategy? No, the pathophysiology may be poorly understood, but there is now solid evidence that type 2 diabetes is a disease of fatness. New, controlled, clinical trials show that as little as 5% weight loss is sufficient to prevent most obese subjects with impaired glucose tolerance developing type 2 diabetes. Since type 2 diabetes is obesity dependent, and obesity is the main aetiogical cause of type 2 diabetes, we propose the term ‘diabesity’ should be adopted.Keywords
This publication has 11 references indexed in Scilit:
- Effects of Weight Loss With Orlistat on Glucose Tolerance and Progression to Type 2 Diabetes in Obese AdultsArchives of internal medicine (1960), 2000
- Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational studyDiabetologia, 2000
- Reduction in Incidence of Diabetes, Hypertension and Lipid Disturbances after Intentional Weight Loss Induced by Bariatric Surgery: the SOS Intervention StudyObesity Research, 1999
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projectionsDiabetes Care, 1998
- Waist circumference reduction and cardiovascular benefits during weight loss in womenInternational Journal of Obesity, 1997
- Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in WomenAnnals of Internal Medicine, 1995
- Obesity, Weight Loss and Prognosis in Type 2 DiabetesDiabetic Medicine, 1990